Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak.

Corogeanu D, Willmes R, Wolke M, Plum G, Utermöhlen O, Krönke M.

BMC Microbiol. 2012 Aug 1;12:160. doi: 10.1186/1471-2180-12-160.

2.

Characteristics of the Shiga-toxin-producing enteroaggregative Escherichia coli O104:H4 German outbreak strain and of STEC strains isolated in Spain.

Mora A, Herrrera A, López C, Dahbi G, Mamani R, Pita JM, Alonso MP, Llovo J, Bernárdez MI, Blanco JE, Blanco M, Blanco J.

Int Microbiol. 2011 Sep;14(3):121-41. Review.

3.

Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.

PMID:
23312798
4.

Molecular epidemiology of a household outbreak of Shiga-toxin-producing Escherichia coli in Poland due to secondary transmission of STEC O104:H4 from Germany.

Januszkiewicz A, Szych J, Rastawicki W, Wołkowicz T, Chróst A, Leszczyńska B, Kuźma E, Roszkowska-Blaim M, Gierczyński R.

J Med Microbiol. 2012 Apr;61(Pt 4):552-8. doi: 10.1099/jmm.0.039289-0. Epub 2011 Dec 1.

PMID:
22135021
5.

A comparison of Shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain.

Laing CR, Zhang Y, Gilmour MW, Allen V, Johnson R, Thomas JE, Gannon VP.

PLoS One. 2012;7(5):e37362. doi: 10.1371/journal.pone.0037362. Epub 2012 May 23.

6.

Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7.

Wöchtl B, Gunzer F, Gerner W, Gasse H, Koch M, Bagó Z, Ganter M, Weissenböck H, Dinhopl N, Coldewey SM, von Altrock A, Waldmann KH, Saalmüller A, Zimmermann K, Steinmann J, Kehrmann J, Klein-Hitpass L, Blom J, Ehricht R, Engelmann I, Hennig-Pauka I.

Gut Pathog. 2017 May 25;9:30. doi: 10.1186/s13099-017-0179-8. eCollection 2017.

7.

[Stx2a-producing enteroaggregative Escherichia coli O104:H4-ST678. Microbiological diagnostic already, for this and other STEC/VTEC serotypes!].

Blanco J.

Enferm Infecc Microbiol Clin. 2012 Feb;30(2):84-9. doi: 10.1016/j.eimc.2011.09.008. Epub 2011 Nov 23. Review. Spanish.

PMID:
22116024
8.

Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4.

Tran SL, Billoud L, Lewis SB, Phillips AD, Schüller S.

Cell Microbiol. 2014 Aug;16(8):1255-66. doi: 10.1111/cmi.12281. Epub 2014 Mar 21.

9.

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, Peters G, Karch H.

Antimicrob Agents Chemother. 2012 Jun;56(6):3277-82. doi: 10.1128/AAC.06315-11. Epub 2012 Mar 5.

10.
11.

Shiga toxin-producing Escherichia coli strains from cattle as a source of the Stx2a bacteriophages present in enteroaggregative Escherichia coli O104:H4 strains.

Beutin L, Hammerl JA, Reetz J, Strauch E.

Int J Med Microbiol. 2013 Dec;303(8):595-602. doi: 10.1016/j.ijmm.2013.08.001. Epub 2013 Aug 16.

PMID:
24012149
12.

A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.

Lu X, Skurnik D, Pozzi C, Roux D, Cywes-Bentley C, Ritchie JM, Munera D, Gening ML, Tsvetkov YE, Nifantiev NE, Waldor MK, Pier GB.

MBio. 2014 Mar 25;5(2):e00974-14. doi: 10.1128/mBio.00974-14.

13.

A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.

Wu CJ, Hsueh PR, Ko WC.

J Microbiol Immunol Infect. 2011 Oct;44(5):390-3. doi: 10.1016/j.jmii.2011.07.001. Epub 2011 Sep 8. Review.

14.

Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.

King LA, Nogareda F, Weill FX, Mariani-Kurkdjian P, Loukiadis E, Gault G, Jourdan-DaSilva N, Bingen E, Macé M, Thevenot D, Ong N, Castor C, Noël H, Van Cauteren D, Charron M, Vaillant V, Aldabe B, Goulet V, Delmas G, Couturier E, Le Strat Y, Combe C, Delmas Y, Terrier F, Vendrely B, Rolland P, de Valk H.

Clin Infect Dis. 2012 Jun;54(11):1588-94. doi: 10.1093/cid/cis255. Epub 2012 Mar 28.

PMID:
22460976
15.

Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H.

PLoS One. 2011;6(7):e22751. doi: 10.1371/journal.pone.0022751. Epub 2011 Jul 20.

16.

Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.

Jandhyala DM, Vanguri V, Boll EJ, Lai Y, McCormick BA, Leong JM.

Infect Dis Clin North Am. 2013 Sep;27(3):631-49. doi: 10.1016/j.idc.2013.05.002. Epub 2013 Jul 24. Review.

17.

Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.

Misselwitz J, Karch H, Bielazewska M, John U, Ringelmann F, Rönnefarth G, Patzer L.

Pediatr Infect Dis J. 2003 Apr;22(4):349-54.

PMID:
12690276
18.

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK.

JAMA. 2012 Mar 14;307(10):1046-52. doi: 10.1001/jama.2012.264.

PMID:
22416100
19.

Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007).

Hiroi M, Takahashi N, Harada T, Kawamori F, Iida N, Kanda T, Sugiyama K, Ohashi N, Hara-Kudo Y, Masuda T.

Jpn J Infect Dis. 2012;65(3):198-202.

20.

Spread of a distinct Stx2-encoding phage prototype among Escherichia coli O104:H4 strains from outbreaks in Germany, Norway, and Georgia.

Beutin L, Hammerl JA, Strauch E, Reetz J, Dieckmann R, Kelner-Burgos Y, Martin A, Miko A, Strockbine NA, Lindstedt BA, Horn D, Monse H, Huettel B, Müller I, Stüber K, Reinhardt R.

J Virol. 2012 Oct;86(19):10444-55. doi: 10.1128/JVI.00986-12. Epub 2012 Jul 18.

Supplemental Content

Support Center